Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
Open Access
- 30 June 2010
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 51 (6), 1486-1495
- https://doi.org/10.1194/jlr.m003566
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound BerberineJournal of Biological Chemistry, 2009
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levelsProceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elementsJournal of Lipid Research, 2009
- Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 CellsOnline Journal of Public Health Informatics, 2009
- Thyroid hormone β receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeysBritish Journal of Pharmacology, 2009
- Plasma PCSK9 preferentially reduces liver LDL receptors in miceJournal of Lipid Research, 2008
- Plasma PCSK9 levels are significantly modified by statins and fibrates in humansLipids in Health and Disease, 2008
- Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosisJournal of Lipid Research, 2007
- Molecular biology of PCSK9: its role in LDL metabolismTrends in Biochemical Sciences, 2007
- The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiationProceedings of the National Academy of Sciences of the United States of America, 2003